Publications found:
73,128
Sort by:
Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices (Smart Insulin Pen and Smart Insulin Pump), Disease, (Type 1 Diabetes and Type 2 Diabetes), and Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting, and Premixed Type): Global Opportunity Analysis and Industry Forecast, 2019–2027
US$ 5,769.00
The global smart insulin or glucose responsive insulin market was valued at $2,773.73 million in 2019 and is expected to reach $6,174.30 million by 2027, registering a CAGR of 10.5 % from 2020 to 2027...
August 2020
231 pages
Rheumatoid Arthritis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
1191 pages
Urinary Incontinence - Pipeline Review, H2 2020
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
80 pages
Autism - Pipeline Review, H2 2020
US$ 2,000.00
... . The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
173 pages
Erectile Dysfunction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
156 pages
Male Hypogonadism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
108 pages
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis (NASH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
1101 pages
Otitis Media - Pipeline Review, H2 2020
US$ 2,000.00
... . The Otitis Media (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
86 pages
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Systemic Sclerosis (Scleroderma) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Sclerosis (Scleroderma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
419 pages
Iron Deficiency Anemia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Iron Deficiency Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Iron Deficiency Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
96 pages
Hepatic Encephalopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatic Encephalopathy (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Hepatic Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
96 pages
Sarcopenia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
98 pages
Alcohol Addiction - Pipeline Review, H2 2020
US$ 2,000.00
... . The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
180 pages
Nocturia - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nocturia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
45 pages
Diabetic Macular Edema - Pipeline Review, H2 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
319 pages
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
218 pages
Traumatic Brain Injury - Pipeline Review, H2 2020
US$ 2,000.00
... . The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
440 pages
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Traumatic Stress Disorder (PTSD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
195 pages
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Reflux Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Reflux Esophagitis (Gastro esophageal Reflux Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
113 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
667 pages
Alopecia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
222 pages
Amyloidosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
241 pages
Anthrax - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
126 pages
Diarrhea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
156 pages
Fatigue - Pipeline Review, H2 2020
US$ 2,000.00
... . The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
37 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
80 pages
Restless Legs Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
63 pages
Smallpox - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
85 pages
Birch Pollen Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
38 pages
Lyme Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
64 pages
Myasthenia Gravis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myasthenia Gravis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Myasthenia Gravis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
254 pages
Obsessive-Compulsive Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Obsessive-Compulsive Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Obsessive-Compulsive Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
60 pages
Thromboembolism - Pipeline Review, H2 2020
US$ 2,000.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Thromboembolism - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Thromboembolism (Cardiovascular) The guide covers the ...
July 2020
128 pages
Warts - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Warts (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Warts and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
112 pages
Post-Operative Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
302 pages
Typhoid Fever - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
53 pages
Hidradenitis Suppurativa - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hidradenitis Suppurativa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
251 pages
Hypoglycemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
87 pages
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2020
US$ 2,000.00
... Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
46 pages
Bacterial Vaginosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
97 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
152 pages
Cholera - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Dilated Cardiomyopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
66 pages
House Dust Mite Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
61 pages
Insulin Resistance - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
52 pages
